EBITDA Margin % is calculated as EBITDA divided by its Revenue. Patron Exim's EBITDA for the
six
months ended in Mar. 2026 was ₹-11.0 Mil. Patron Exim's Revenue for the
six
months ended in Mar. 2026 was ₹4.9 Mil. Therefore, Patron Exim's EBITDA margin for the quarter that ended in Mar. 2026 was -226.28%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Patron Exim EBITDA Margin % Related Terms
Patron Exim EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Patron Exim's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Patron Exim's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Patron Exim EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Patron Exim's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Patron Exim's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Patron Exim (BOM:543798) has a EBITDA Margin % of -226.28% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Patron Exim and its competitors. According to the industry distribution chart, Patron Exim ranks #1383 out of 1585 companies in the Chemicals industry, placing it in the top 87.3%.
Is Patron Exim's EBITDA Margin % too high?
Patron Exim's current EBITDA Margin % is -226.28%. Based on the distribution chart, Patron Exim ranks #1383 out of 1585 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Patron Exim has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Patron Exim's EBITDA Margin % compare to DOW?
According to the Chemicals industry distribution chart, Patron Exim ranks #1383 out of 1585 companies for EBITDA Margin %. This places Patron Exim in the lower half of its industry. The industry median EBITDA Margin % is 9.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.63, based on 1,585 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Patron Exim and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Patron Exim's current EBITDA Margin % is -226.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Patron Exim stock overvalued right now?
Based on GuruFocus' analysis, Patron Exim (BOM:543798) is currently considered Possible Value Trap. The stock's GF Value™ is ₹25.61, compared to a current price of ₹2.19 — trading 91.4% below its estimated fair value. The current EBITDA Margin % is -226.28%. Patron Exim's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Patron Exim (BOM:543798), the current EBITDA Margin % is -226.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Patron Exim (BOM:543798) Overvalued in 2026?
Based on GuruFocus' analysis, Patron Exim stock appears to be undervalued.
The current stock price of ₹2.19 is trading 91.4% below its estimated GF Value™ of ₹25.61.
GuruFocus considers Patron Exim to be Possible Value Trap.
Key valuation signals for BOM:543798:
EBITDA Margin %: -226.28%
GF Value™: ₹25.61 vs. price of ₹2.19 (91.4% below fair value)
No single metric tells the full story. See the BOM:543798 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Patron Exim Ltd is engaged in the trading and distribution of pharmaceutical raw material, which is also known as APIs (Active Pharmaceutical Ingredients), industrial, excipient and solvents. Its product portfolio comprises of around 150 AIPs, Excipient, Pharma Chemical & Intermediates. It is also in the trading of a variety of chemicals, such as Petrochemicals, Dyes & Pigment Chemicals, Paints & Speciality Chemical, Agro Chemicals, Oil & Refinery Chemicals, Foam & Adhesive, Plywood & Laminates Chemical. The Chemicals also include food industry & water treatment chemicals, resins & plastics chemicals, polymers and additives etc. The Company is mainly dealing in Pharmaceutical Business i.e. trading of pharma products and commission agent in pharma products etc.
60GF Score
Get the complete analysis for BOM:543798
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543798 has been successfully added to your 
